These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison]. Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247 [TBL] [Abstract][Full Text] [Related]
29. Dobutamine infusion for the treatment of congestive heart failure in the home care setting. Coffin MR J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608 [TBL] [Abstract][Full Text] [Related]
31. Inotropic therapy in the home care setting: criteria, management, and implications. Mayes J; Carter C; Adams JE J Intraven Nurs; 1995; 18(6):301-6. PubMed ID: 8699289 [TBL] [Abstract][Full Text] [Related]
32. Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol. Hastenteufel LCT; Clausell N; Neyeloff JL; Domingues FB; Caballero LG; Silva ERRD; Goldraich LA Arq Bras Cardiol; 2019 Jun; 112(5):573-576. PubMed ID: 31188963 [TBL] [Abstract][Full Text] [Related]
33. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home. Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175 [TBL] [Abstract][Full Text] [Related]
34. Chronic inotropic therapy in end-stage heart failure. Hauptman PJ; Mikolajczak P; George A; Mohr CJ; Hoover R; Swindle J; Schnitzler MA Am Heart J; 2006 Dec; 152(6):1096.e1-8. PubMed ID: 17161059 [TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Baruch L; Patacsil P; Hameed A; Pina I; Loh E Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341 [TBL] [Abstract][Full Text] [Related]
36. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure. Moga VD; Luca C; Luca CT; Branea H; Drăgulescu SI Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942 [TBL] [Abstract][Full Text] [Related]
37. Hydralazine and nitrates: beyond race and ethnicity. Ghali JK J Card Fail; 2007 Apr; 13(3):238. PubMed ID: 17448423 [No Abstract] [Full Text] [Related]
38. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261 [TBL] [Abstract][Full Text] [Related]
39. To infuse or not? Habet KJ Chest; 2004 Apr; 125(4):1182-3. PubMed ID: 15078718 [No Abstract] [Full Text] [Related]
40. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure]. Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]